Taiwan fines citizens more for importing cotton swabs than for drunk driving, while lifesaving heart-monitoring devices remain out of reach. It is a system that punishes the trivial and neglects the essential. In Taiwan, you can be fined hundreds of thousands of New Taiwan dollars for something as trivial as ordering cotton swabs from an overseas Web site. At the same time, patients who need lifesaving medical devices — such as long-term electrocardiogram (ECG) monitors that detect dangerous heart rhythms — often cannot get them.
Consider a recent case that made headlines: A woman was fined NT$100,000 for buying cotton swabs from Taobao two years earlier. The swabs had long since been confiscated and destroyed. Yet the penalty came years later, delivered with the weight of a criminal conviction. Strikingly, the fine is harsher than what a first-time drunk driver would face.
The comparison is absurd. Cotton swabs might cause a minor self-injury. Drunk driving can kill. Only in Taiwan’s regulatory logic does the answer to which one deserves the greater punishment come out upside down.
In Taiwan, the standard Holter monitor records heart rhythms for only 24 hours. Yet we know from international evidence that arrhythmias — including atrial fibrillation and dangerous pauses — are often intermittent and might not appear within such a short window. Multi-day or even two-week continuous ECG patches have been the norm in the US, Europe and even parts of China for years. The benefits are obvious: better diagnostic yield, earlier detection and potentially the prevention of sudden cardiac death.
Taiwan is not lacking the technology. Although the product came late, at least it exists — a small consolation and a sign of potential. In 2022, a local company launched a multi-day ECG patch, even winning a Taiwan Excellence Award. Despite the recognition, patients who might benefit from it often cannot get it — blocked by tight reimbursement rules, regulatory inertia or distribution barriers.
Some patients wait months for symptoms to be detected with outdated 24-hour monitors, enduring repeated hospital visits. In other countries, a simple patch worn for a week could provide answers in days. Clinicians are asked to deliver world-class care with second-tier tools, while regulators congratulate themselves for keeping “order” in the market.
Regulators defend harsh penalties on imports to stop profiteering and protect consumers. The logic collapses under scrutiny. If a patient imports a glucose monitor or ECG patch for personal use, who is harmed?
This imbalance undermines trust in the entire system. Patients with urgent medical needs hear that the latest devices — already made in Taiwan — are unavailable to them. They sense that the system is not designed for their health, but to protect entrenched distributors and preserve outdated market structures.
By sealing off access to advanced tools, the current framework delays diagnoses, prolongs suffering and risks preventable deaths.
Taiwan rightly takes pride in its healthcare system and its reputation for innovation. However, it risks becoming a place where excellence is celebrated, but withheld from patients. True reform means more than slapping fines on trivial infractions. It means opening pathways so patients and clinicians can access the best tools available — even if that means loosening monopolies and questioning outdated laws.
Protecting lives must matter more than protecting the market for cotton swabs. Taiwan has spent too long over-regulating the trivial, while neglecting the essential. It is time to flip the priorities and finally put patients first.
Chu Jou-juo is a professor in the Department of Labor Relations at National Chung Cheng University.
On Sept. 3 in Tiananmen Square, the Chinese Communist Party (CCP) and the People’s Liberation Army (PLA) rolled out a parade of new weapons in PLA service that threaten Taiwan — some of that Taiwan is addressing with added and new military investments and some of which it cannot, having to rely on the initiative of allies like the United States. The CCP’s goal of replacing US leadership on the global stage was advanced by the military parade, but also by China hosting in Tianjin an August 31-Sept. 1 summit of the Shanghai Cooperation Organization (SCO), which since 2001 has specialized
In an article published by the Harvard Kennedy School, renowned historian of modern China Rana Mitter used a structured question-and-answer format to deepen the understanding of the relationship between Taiwan and China. Mitter highlights the differences between the repressive and authoritarian People’s Republic of China and the vibrant democracy that exists in Taiwan, saying that Taiwan and China “have had an interconnected relationship that has been both close and contentious at times.” However, his description of the history — before and after 1945 — contains significant flaws. First, he writes that “Taiwan was always broadly regarded by the imperial dynasties of
The Chinese Communist Party (CCP) will stop at nothing to weaken Taiwan’s sovereignty, going as far as to create complete falsehoods. That the People’s Republic of China (PRC) has never ruled Taiwan is an objective fact. To refute this, Beijing has tried to assert “jurisdiction” over Taiwan, pointing to its military exercises around the nation as “proof.” That is an outright lie: If the PRC had jurisdiction over Taiwan, it could simply have issued decrees. Instead, it needs to perform a show of force around the nation to demonstrate its fantasy. Its actions prove the exact opposite of its assertions. A
A large part of the discourse about Taiwan as a sovereign, independent nation has centered on conventions of international law and international agreements between outside powers — such as between the US, UK, Russia, the Republic of China (ROC) and Japan at the end of World War II, and between the US and the People’s Republic of China (PRC) since recognition of the PRC as the sole representative of China at the UN. Internationally, the narrative on the PRC and Taiwan has changed considerably since the days of the first term of former president Chen Shui-bian (陳水扁) of the Democratic